Intraoperative Radiation Therapy Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

IORT encompasses radiation delivery systems used during surgical procedures, primarily for breast cancer, soft tissue sarcomas, and select neuro-oncology applications. The market includes mobile electron accelerators, low-energy X-ray devices, and brachytherapy applicators designed for use in operating rooms. Valued at roughly $145 million in 2025, the market reflects steady adoption across major oncology centers in North America, Europe, and parts of the Asia-Pacific region.

• •Single-dose, localized radiation delivered in the operating room immediately after tumor resection
• •Primary applications include breast-conserving therapy, soft tissue sarcoma, and select pediatric and brain tumor cases
• •Market size estimated at approximately $145 million USD in 2025 with 7.62% annual growth projected

Rising global cancer incidence, particularly breast cancer, is a primary catalyst, as IORT offers a clinically convenient alternative to the multi-week external beam radiation schedules traditionally required. Clinical evidence showing comparable local control rates and reduced radiation exposure to surrounding healthy tissue has encouraged oncologist and surgeon adoption. Additionally, healthcare systems' interest in cost-effective, time-efficient treatment protocols supports market expansion.

• •Increasing cancer prevalence worldwide, especially breast cancer, driving demand for single-fraction treatment alternatives
• •Clinical studies demonstrating reduced local recurrence rates and improved cosmetic outcomes compared to conventional radiation
• •Healthcare cost-containment pressures favoring shorter, integrated treatment workflows that reduce patient visits

The market is commonly segmented by technology into IOERT (Intraoperative Electron Radiation Therapy) and brachytherapy-based IORT systems, each serving distinct clinical and institutional preferences. Geographically, North America holds the largest share due to advanced oncology infrastructure and favorable reimbursement environments, followed by Europe with strong academic medical center adoption. The Asia-Pacific region is emerging as a growth market as healthcare modernization expands access to advanced radiotherapy in countries including China, India, and Japan.

• •Technology split: electron-based IOERT systems and low-energy X-ray/brachytherapy IORT devices
• •North America leads in market share, supported by established reimbursement pathways and high cancer treatment volumes
• •Asia-Pacific expected to show above-average growth driven by rising healthcare investment and expanding cancer care capacity

What are the recent trends and outlook?

Miniaturization of radiation delivery devices and integration with robotic surgical platforms represent key technology trends that may broaden IORT's clinical indications beyond current oncology applications. Artificial intelligence-assisted treatment planning and real-time dose verification are increasingly incorporated into newer system generations. The market is expected to continue its steady growth trajectory through 2035, with expansion driven by clinical validation in new tumor sites, improved device portability, and evolving reimbursement frameworks in emerging markets.

• •Growing exploration of IORT for additional indications including brain tumors, head and neck cancers, and gynecological malignancies
• •AI-powered treatment planning and dose-monitoring technologies improving precision and reducing operator dependency
• •Projected sustained growth through 2035 as reimbursement pathways mature and clinical evidence base expands